Xinxin Ci Selected Research

farrerol

1/2021	Farrerol Ameliorated Cisplatin-Induced Chronic Kidney Disease Through Mitophagy Induction via Nrf2/PINK1 Pathway.
1/2019	Farrerol Ameliorates APAP-induced Hepatotoxicity via Activation of Nrf2 and Autophagy.
1/2019	Farrerol Attenuates Cisplatin-Induced Nephrotoxicity by Inhibiting the Reactive Oxygen Species-Mediated Oxidation, Inflammation, and Apoptotic Signaling Pathways.
1/2012	Different effects of farrerol on an OVA-induced allergic asthma and LPS-induced acute lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinxin Ci Research Topics

Disease

16	Inflammation (Inflammations) 02/2022 - 08/2009
15	Acute Lung Injury 11/2019 - 12/2011
8	Lung Injury 01/2022 - 01/2017
8	Asthma (Bronchial Asthma) 01/2015 - 04/2011
7	Mitochondrial Diseases (Mitochondrial Disease) 06/2020 - 12/2016
6	Neoplasms (Cancer) 04/2021 - 04/2012
6	Pulmonary Edema 01/2019 - 04/2012
5	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2019
4	Pleurisy (Pleuritis) 05/2022 - 03/2020
4	Ovarian Neoplasms (Ovarian Cancer) 06/2021 - 02/2021
4	Acute Liver Failure (Fulminant Hepatic Failure) 11/2018 - 12/2016
4	Hyperplasia 07/2012 - 04/2011
3	Respiratory Hypersensitivity 07/2012 - 01/2012
2	Fibrosis (Cirrhosis) 01/2021 - 05/2020
2	Chronic Renal Insufficiency 01/2021 - 10/2020
2	Infections 02/2020 - 07/2008
2	Necrosis 12/2016 - 09/2015
2	Hemorrhage 10/2012 - 04/2012
2	Airway Remodeling 02/2012 - 06/2011
2	Endotoxemia 12/2008 - 07/2008
2	Gram-Negative Bacterial Infections 12/2008 - 01/2008
2	Shock 07/2008 - 01/2008
1	Non-alcoholic Fatty Liver Disease 02/2022
1	Atherosclerosis 02/2022
1	Metabolic Diseases (Metabolic Disease) 02/2022
1	Primary Ovarian Insufficiency 01/2022
1	Bacterial Infections (Bacterial Infection) 07/2021
1	Rheumatoid Arthritis 07/2021
1	Skin Neoplasms (Skin Cancer) 04/2021
1	Chronic Disease (Chronic Diseases) 02/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2020

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2009
13	LipopolysaccharidesIBA 05/2020 - 01/2008
9	CytokinesIBA 01/2021 - 01/2008
8	Pharmaceutical PreparationsIBA 02/2022 - 07/2008
8	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2019
8	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2021 - 01/2017
7	AntioxidantsIBA 07/2021 - 01/2016
7	OvalbuminIBA 01/2015 - 04/2011
5	daphnetinIBA 01/2022 - 01/2017
4	CarrageenanIBA 05/2022 - 03/2020
4	FlavonoidsIBA 01/2022 - 04/2012
4	farrerolIBA 01/2021 - 01/2012
4	Cytochromes c (Cytochrome c)IBA 06/2020 - 01/2018
4	Apoptosis Inducing FactorIBA 06/2020 - 12/2016
4	InflammasomesIBA 04/2020 - 01/2017
4	Peroxidase (Myeloperoxidase)IBA 01/2019 - 04/2012
3	Malondialdehyde (Propanedial)IBA 01/2022 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 07/2021 - 07/2008
3	diosmetinIBA 06/2021 - 03/2018
3	Caspase 3 (Caspase-3)IBA 05/2020 - 01/2018
3	oridoninIBA 04/2020 - 01/2019
3	EnzymesIBA 01/2020 - 04/2012
3	Eosine Yellowish-(YS) (Eosin)IBA 11/2019 - 12/2011
3	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2018 - 12/2016
3	JNK Mitogen-Activated Protein KinasesIBA 01/2018 - 08/2009
3	NF-kappa B (NF-kB)IBA 10/2012 - 08/2009
2	leonurineIBA 05/2022 - 01/2022
2	isoliquiritigenin (GU 17)IBA 03/2020 - 01/2017
2	NLR ProteinsIBA 03/2020 - 01/2017
2	Hematoxylin (Haematoxylon)IBA 11/2019 - 07/2012
2	GalactosamineIBA 11/2018 - 01/2017
2	tert-ButylhydroperoxideIBA 01/2018 - 01/2017
2	Superoxide DismutaseIBA 01/2018 - 01/2017
2	Glutathione Disulfide (GSSG)FDA LinkGeneric 01/2018 - 01/2017
2	tenuigeninIBA 01/2016 - 09/2015
2	Mitogen-Activated Protein KinasesIBA 10/2012 - 09/2011
2	Alcian BlueIBA 07/2012 - 12/2011
2	Periodic AcidIBA 07/2012 - 12/2011
2	Phosphotransferases (Kinase)IBA 07/2012 - 08/2009
2	MitogensIBA 07/2012 - 08/2009
2	Immunoglobulin E (IgE)IBA 07/2012 - 01/2012
2	Methacholine Chloride (Methacholine)FDA Link 02/2012 - 01/2012
1	Therapeutic UsesIBA 05/2022
1	LipidsIBA 02/2022
1	amentoflavoneIBA 01/2022
1	IronIBA 01/2022
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2022
1	AlkaloidsIBA 01/2022
1	Lipid PeroxidesIBA 01/2022
1	AminoglycosidesIBA 07/2021
1	CoumarinsIBA 07/2021
1	Gentamicins (Gentamicin)FDA LinkGeneric 07/2021
1	Acetylcysteine (Siran)FDA LinkGeneric 04/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2021
1	Cysteine (L-Cysteine)FDA Link 02/2021
1	hyperosideIBA 01/2021
1	Particulate MatterIBA 01/2021
1	ElementsIBA 10/2020
1	CollagenIBA 05/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2020
1	CaspasesIBA 05/2020
1	pterostilbeneIBA 05/2020
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 05/2020
1	Hydroxyproline (4 Hydroxyproline)IBA 05/2020

Therapy/Procedure

1	Therapeutics 02/2021
1	Drug Therapy (Chemotherapy) 02/2021